We are analyzing https://link.springer.com/article/10.1186/s12943-020-01234-1.

Title:
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects | Molecular Cancer
Description:
Regulatory T cells (Tregs) characterized by the expression of the master transcription factor forkhead box protein p3 (Foxp3) suppress anticancer immunity, thereby hindering protective immunosurveillance of tumours and hampering effective antitumour immune responses in tumour-bearing hosts, constitute a current research hotspot in the field. However, Tregs are also essential for the maintenance of the immune tolerance of the body and share many molecular signalling pathways with conventional T cells, including cytotoxic T cells, the primary mediators of tumour immunity. Hence, the inability to specifically target and neutralize Tregs in the tumour microenvironment without globally compromising self-tolerance poses a significant challenge. Here, we review recent advances in characterizing tumour-infiltrating Tregs with a focus on the functional roles of costimulatory and inhibitory receptors in Tregs, evaluate their potential as clinical targets, and systematically summarize their roles in potential treatment strategies. Also, we propose modalities to integrate our increasing knowledge on Tregs phenotype and function for the rational design of checkpoint inhibitor-based combination therapies. Finally, we propose possible treatment strategies that can be used to develop Treg-targeted therapies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

tregs, pubmed, cells, article, google, scholar, cas, regulatory, central, cell, cancer, function, foxp, expression, tumour, immune, immunol, effector, immunity, suppressive, treg, activation, tumours, depletion, human, ctla, wang, antitumour, signalling, nat, activity, res, tcell, mice, zhang, transcription, enhanced, blockade, receptor, antictla, tumor, immunotherapy, control, ifnγ, liu, differentiation, development, patients, treatment, metabolism,

Topics {✒️}

foxo1/cebpb/nf-κb/ccl20 axis fc-region–modified anti-ctla-4 mab anti-cd3/cd28/cd2-induced proliferation foxo1/cebpb/nf-kappab signaling peroxisome proliferator-activated receptor-beta fc-engineered anti-ctla-4 antibody foxo1/cebpb/nf-κb signalling pi3k/akt/foxo1/3 signalling cascade antibody-dependent macrophage-mediated depletion de-fucosylated anti-ccr4 antibody irae-prone anti-ctla-4 mab nf-kappab c-rel amplify il-2r-stat5 signaling excessive th2-type-dominant responses isoform-specific inhibitor effective article download pdf long-lived central tregs tumor-specific treg-targeted antibodies cancer cell-derived il-1α pro-autophagy protein ambra1 fatty acid-binding proteins anti-pd-1/pd-l1 therapy [178] cell-driven hev neogenesis gr-1+cd11b+ myeloid cells ph-sensitive anti-ctla-4 antibodies treg-specific demethylated region serine-threonine kinase mst1 activated β-catenin signature mtorc1-hif-1α axis transcription factors t-bet activates latent tgf-β enterotoxigenic bacteroides fragilis cell-derived interferon-gamma form stat3-foxp3 complexes ti-tregs produce ifn-γ single-cell rna-sequencing anti-tim-3-treated mice showed malt1 protease-dependent manner il-2-fc fusion proteins treg-expressing ctla-4 combines adult t-cell leukemia k-akt-mtorc1 signalling tumor-infiltrating human cd4 hif-1α bound directly tumour-producing chemokine ccl17 tumour antigen-selective manner anti-ctla-4 antibody treatment tgf-β-dependent manner combining treg-targeting therapies tlr8 signalling-mediated reprogramming

Questions {❓}

Do suppressor T cells exist?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
         description:Regulatory T cells (Tregs) characterized by the expression of the master transcription factor forkhead box protein p3 (Foxp3) suppress anticancer immunity, thereby hindering protective immunosurveillance of tumours and hampering effective antitumour immune responses in tumour-bearing hosts, constitute a current research hotspot in the field. However, Tregs are also essential for the maintenance of the immune tolerance of the body and share many molecular signalling pathways with conventional T cells, including cytotoxic T cells, the primary mediators of tumour immunity. Hence, the inability to specifically target and neutralize Tregs in the tumour microenvironment without globally compromising self-tolerance poses a significant challenge. Here, we review recent advances in characterizing tumour-infiltrating Tregs with a focus on the functional roles of costimulatory and inhibitory receptors in Tregs, evaluate their potential as clinical targets, and systematically summarize their roles in potential treatment strategies. Also, we propose modalities to integrate our increasing knowledge on Tregs phenotype and function for the rational design of checkpoint inhibitor-based combination therapies. Finally, we propose possible treatment strategies that can be used to develop Treg-targeted therapies.
         datePublished:2020-07-17T00:00:00Z
         dateModified:2020-07-17T00:00:00Z
         pageStart:1
         pageEnd:23
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-020-01234-1
         keywords:
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig4_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Chunxiao Li
               url:http://orcid.org/0000-0002-1805-140X
               affiliation:
                     name:Peking University Third Hospital
                     address:
                        name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ping Jiang
               affiliation:
                     name:Peking University Third Hospital
                     address:
                        name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuhua Wei
               affiliation:
                     name:Peking University Third Hospital
                     address:
                        name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaofei Xu
               affiliation:
                     name:Peking University Third Hospital
                     address:
                        name:Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
                     name:Peking University
                     address:
                        name:National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junjie Wang
               affiliation:
                     name:Peking University Third Hospital
                     address:
                        name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
      description:Regulatory T cells (Tregs) characterized by the expression of the master transcription factor forkhead box protein p3 (Foxp3) suppress anticancer immunity, thereby hindering protective immunosurveillance of tumours and hampering effective antitumour immune responses in tumour-bearing hosts, constitute a current research hotspot in the field. However, Tregs are also essential for the maintenance of the immune tolerance of the body and share many molecular signalling pathways with conventional T cells, including cytotoxic T cells, the primary mediators of tumour immunity. Hence, the inability to specifically target and neutralize Tregs in the tumour microenvironment without globally compromising self-tolerance poses a significant challenge. Here, we review recent advances in characterizing tumour-infiltrating Tregs with a focus on the functional roles of costimulatory and inhibitory receptors in Tregs, evaluate their potential as clinical targets, and systematically summarize their roles in potential treatment strategies. Also, we propose modalities to integrate our increasing knowledge on Tregs phenotype and function for the rational design of checkpoint inhibitor-based combination therapies. Finally, we propose possible treatment strategies that can be used to develop Treg-targeted therapies.
      datePublished:2020-07-17T00:00:00Z
      dateModified:2020-07-17T00:00:00Z
      pageStart:1
      pageEnd:23
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-020-01234-1
      keywords:
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-020-01234-1/MediaObjects/12943_2020_1234_Fig4_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Chunxiao Li
            url:http://orcid.org/0000-0002-1805-140X
            affiliation:
                  name:Peking University Third Hospital
                  address:
                     name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ping Jiang
            affiliation:
                  name:Peking University Third Hospital
                  address:
                     name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuhua Wei
            affiliation:
                  name:Peking University Third Hospital
                  address:
                     name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaofei Xu
            affiliation:
                  name:Peking University Third Hospital
                  address:
                     name:Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
                  name:Peking University
                  address:
                     name:National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junjie Wang
            affiliation:
                  name:Peking University Third Hospital
                  address:
                     name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:19
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Peking University Third Hospital
      address:
         name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
         type:PostalAddress
      name:Peking University Third Hospital
      address:
         name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
         type:PostalAddress
      name:Peking University Third Hospital
      address:
         name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
         type:PostalAddress
      name:Peking University Third Hospital
      address:
         name:Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
         type:PostalAddress
      name:Peking University
      address:
         name:National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University, Beijing, China
         type:PostalAddress
      name:Peking University Third Hospital
      address:
         name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Chunxiao Li
      url:http://orcid.org/0000-0002-1805-140X
      affiliation:
            name:Peking University Third Hospital
            address:
               name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ping Jiang
      affiliation:
            name:Peking University Third Hospital
            address:
               name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      name:Shuhua Wei
      affiliation:
            name:Peking University Third Hospital
            address:
               name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      name:Xiaofei Xu
      affiliation:
            name:Peking University Third Hospital
            address:
               name:Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
               type:PostalAddress
            type:Organization
            name:Peking University
            address:
               name:National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University, Beijing, China
               type:PostalAddress
            type:Organization
      name:Junjie Wang
      affiliation:
            name:Peking University Third Hospital
            address:
               name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
      name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
      name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
      name:Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
      name:National Clinical Research Center for Obstetrics and Gynecology, Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University, Beijing, China
      name:Department of Radiation Oncology, Peking University Third Hospital, Beijing, China

External Links {🔗}(725)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.09s.

LINK . SPRINGER . COM {}